Day: November 8, 2018

The Carlyle Group (NASDAQ: CG) has made a strategic investment in alternative investments platform iCapital Network.

The Carlyle Group (NASDAQ: CG) has made a strategic investment in alternative investments platform iCapital Network.

Abacus Group, a provider of hosted IT solutions and application hosting for alternative investment firms, has completed the acquisition of Hedgepoint Solutions, a boutique IT consulting firm based in New York City.

Abacus Group, a provider of hosted IT solutions and application hosting for alternative investment firms, has completed the acquisition of Hedgepoint Solutions, a boutique IT consulting firm based in New York City.

Law firm Paul Hastings has advised shareholders and re-investors of France-based Aries Alliance, a manufacturer of machine tools, titanium wing structures, and engine parts for the aerospace sector, in connection with the LBO of the group, structured by Astorg Partners, which acquired a majority stake.  

Law firm Paul Hastings has advised shareholders and re-investors of France-based Aries Alliance, a manufacturer of machine tools, titanium wing structures, and engine parts for the aerospace sector, in connection with the LBO of the group, structured by Astorg Partners, which acquired a majority stake.  

Middle market private equity firm One Equity Partners (OEP) is to sell PeroxyChem, a worldwide manufacturer of peroxygen chemistries, to German Evonik Industries AG, a publicly-traded global speciality chemicals company, for USD625 million, or 10.4 times EBITDA, before synergies.

Middle market private equity firm One Equity Partners (OEP) is to sell PeroxyChem, a worldwide manufacturer of peroxygen chemistries, to German Evonik Industries AG, a publicly-traded global speciality chemicals company, for USD625 million, or 10.4 times EBITDA, before synergies.

FreeOx Biotech, a spin-out of Hospital Clinic Barcelona-IDIBAPS which is developing a new class of neuroprotective drugs, has closed its first round of funding with EUR500,000 from private investors Montserrat Esteve and Francisco Javier Alsina.

FreeOx Biotech, a spin-out of Hospital Clinic Barcelona-IDIBAPS which is developing a new class of neuroprotective drugs, has closed its first round of funding with EUR500,000 from private investors Montserrat Esteve and Francisco Javier Alsina.